Modulation of the effect of arginine-vasopressin on water and ion transport in the newt early distal tubule and frog urinary bladder by V1-antagonists
- PMID: 8594534
- DOI: 10.1007/BF01837415
Modulation of the effect of arginine-vasopressin on water and ion transport in the newt early distal tubule and frog urinary bladder by V1-antagonists
Abstract
In the early distal tubule of the newt Triturus vulgaris L., 1 nM arginine-vasopressin (AVP) increased water reabsorption; the fractional reabsorption of Na+ was elevated from 46.2 +/- 6.9% to 67.8 +/- 3.9% (P < 0.001), of Cl- from 52.7 +/- 6.7% to 73.1 +/- 3.5% (P < 0.001), of Mg2+ from 48.0 +/- 7.7% to 71.7 +/- 6.3% (P < 0.001). When V1-receptors were blocked by 1 nM peptide V1-antagonist [1-(beta-mercapto-beta,beta-cyclopentamethylene propionic acid), 2-(O-methyl) Tyr]-[Arg8]vasopressin, 1 nM AVP increased the fractional reabsorption of fluid by 8.9% of Na+ by 10.7% and of Cl- by 11.2%, as compared with the effect of AVP alone. The fractional reabsorption of Ca2+ after addition of AVP did not differ from control; when V1-receptors were blocked in the presence of AVP, the fractional reabsorption of Ca2+ was increased by AVP. The V1-receptor block in the presence of AVP did not change the fractional reabsorption of Mg2+. Experiments on the urinary bladder of the frog Rana temporaria L. showed that 1 nM SR 49059, a non-peptide antagonist of V1a-receptors, like the peptide V1-antagonist, enhanced the AVP effect by 29%. Inhibition of protein kinase C activity by calphostin C (1 nM) mimicked the effect of V1-antagonists; the AVP hydroosmotic effect was increased by 60%. The results obtained indicate that V1-receptors modulate the effects of V2-receptor activation: their block is accompanied by an enhancement of the AVP hydroosmotic effect in the frog urinary bladder and by an increase of Na+ and Cl- reabsorption in the newt early distal tubule. The enhancement of the AVP effect owing to the V1-receptor activation seems to be mediated by a decrease in protein kinase C activity.
Similar articles
-
Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.Gen Physiol Biophys. 1992 Aug;11(4):359-76. Gen Physiol Biophys. 1992. PMID: 1426981
-
V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.Am J Physiol. 1993 Jul;265(1 Pt 2):F35-45. doi: 10.1152/ajprenal.1993.265.1.F35. Am J Physiol. 1993. PMID: 8342613
-
Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humans.Hypertension. 1997 Nov;30(5):1121-7. doi: 10.1161/01.hyp.30.5.1121. Hypertension. 1997. PMID: 9369265 Clinical Trial.
-
The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review.Int J Mol Sci. 2023 Jan 20;24(3):2119. doi: 10.3390/ijms24032119. Int J Mol Sci. 2023. PMID: 36768443 Free PMC article. Review.
-
The effect of vasopressin on the cytoskeleton of the epithelial cell.Pediatr Nephrol. 1993 Oct;7(5):672-9. doi: 10.1007/BF00852577. Pediatr Nephrol. 1993. PMID: 8251343 Review.
Cited by
-
The origin of the hydroosmotic effect of arginine vasopressin: a hypothesis.Dokl Biol Sci. 2003 Mar-Apr;389:96-8. doi: 10.1023/a:1023498104157. Dokl Biol Sci. 2003. PMID: 12854399 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous